Role of Tim-3 in COVID-19: a potential biomarker and therapeutic target

被引：2

作者：

Ma, Haodong ^{[1
]}

Ren, Shengju ^{[1
]}

Meng, Qingpeng ^{[1
]}

Su, Boyuan ^{[1
]}

Wang, Kun ^{[1
]}

Liu, YiChen ^{[1
]}

Wang, Junpeng ^{[2
]}

Ding, Degang ^{[2
]}

Li, Xin ^{[1
,3
,4
]}

机构：

[1] Zhengzhou Univ, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou 450001, Henan, Peoples R China

[2] Zhengzhou Univ Peoples Hosp, Henan Prov Peoples Hosp, Dept Urol, Zhengzhou 450003, Henan, Peoples R China

[3] Zhengzhou Univ, Collaborat Innovat Ctr Henan Prov Canc Chemopreven, Zhengzhou 450001, Henan, Peoples R China

[4] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Henan, Peoples R China

来源：

ARCHIVES OF VIROLOGY | 2023年 / 168卷 / 08期

基金：

中国国家自然科学基金;

关键词：

Tim-3; COVID-19; Immune response; T-CELL EXHAUSTION; BLOCKADE; AUTOIMMUNE; RESPONSES; PD-1; EXPRESSION; APOPTOSIS; RESTORES;

D O I：

10.1007/s00705-023-05842-2

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

T cell immunoglobulin and mucin domain containing protein 3 (Tim-3), an immune checkpoint, is important for maintaining immune tolerance. There is increasing evidence that Tim-3 is aberrantly expressed in patients with COVID-19, indicating that it may play an important role in COVID-19. In this review, we discuss the altered expression and potential role of Tim-3 in COVID-19. The expression of Tim-3 and its soluble form (sTim-3) has been found to be upregulated in COVID-19 patients. The levels of Tim-3 on T cells and circulating sTim-3 have been shown to be associated with the severity of COVID-19, suggesting that this protein could be a potential biomarker of COVID-19. Moreover, this review also highlights the potential of Tim-3 as a therapeutic target of COVID-19.

引用

页数：8

共 50 条

[11] TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia
Kikushige, Yoshikane
Akashi, Koichi
HEMATOPOIETIC STEM CELLS VIII, 2012, 1266 : 118 - 123
[12] The Role of Inflammasomes in COVID-19: Potential Therapeutic Targets
Sun, Chen
Zhao, Hangyuan
Han, Yunze
Wang, Yiqing
Sun, Xiao
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2022, 42 (08) : 406 - 420
[13] The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19
Braga, Cassia L.
Silva-Aguiar, Rodrigo P.
Battaglini, Denise
Peruchetti, Diogo B.
Robba, Chiara
Pelosi, Paolo
Rocco, Patricia R. M.
Caruso-Neves, Celso
Silva, Pedro L.
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (04):
[14] Tim-3-Biomarker and therapeutic target in oncology
Granier, Clemence
Gey, Alain
Dariane, Charles
Mejean, Arnaud
Timsit, Marc-Olivier
Blanc, Charlotte
Verkarre, Virginie
Radulescu, Camelia
Fabre, Elisabeth
Vano, Yann
Oudard, Stephane
Badoual, Cecile
Tartour, Eric
M S-MEDECINE SCIENCES, 2018, 34 (03): : 231 - 237
[15] Tim-3 and its role in regulating anti-tumor immunity
Das, Madhumita
Zhu, Chen
Kuchroo, Vijay K.
IMMUNOLOGICAL REVIEWS, 2017, 276 (01) : 97 - 111
[16] TIM-3, a promising target for cancer immunotherapy
He, Yayi
Cao, Jie
Zhao, Chao
Li, Xuefei
Zhou, Caicun
Hirsch, Fred R.
ONCOTARGETS AND THERAPY, 2018, 11 : 7005 - 7009
[17] A20 as a Potential Therapeutic Target for COVID-19
Wu, Yongyao
He, Lilan
Li, Rong
Li, Jiuxuan
Zhao, Qing
Shao, Bin
IMMUNITY INFLAMMATION AND DISEASE, 2025, 13 (01)
[18] Role of TIM-3 in ovarian cancer
Xu, Y.
Zhang, H.
Huang, Y.
Rui, X.
Zheng, F.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (09) : 1079 - 1083
[19] The role of NO in COVID-19 and potential therapeutic strategies
Fang, Wanyi
Jiang, Jingrui
Su, Lei
Shu, Tong
Liu, Huan
Lai, Shenghan
Ghiladi, Reza A.
Wang, Jun
FREE RADICAL BIOLOGY AND MEDICINE, 2021, 163 : 153 - 162
[20] The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
Wang, Xiaofang
Yi, Panpan
Liang, Yuejin
FRONTIERS IN IMMUNOLOGY, 2021, 12

← 1 2 3 4 5 →